/ Not yet recruitingNot Applicable A phase IIa, multi-center, randomized, double-blind, vehicle-controlled study to determine antipsoriatic efficacy and safety of topical CEP-701 (lestaurtinib) cream formulations in patients with psoriasis vulgaris - POC Psoriasis
/ Not yet recruitingNot Applicable Determination of antipsoriatic efficacy of topical paroxetine hydrochloride ointments in a psoriasis plaque test
100 Clinical Results associated with Perrigo Israel Pharmaceuticals Ltd.
0 Patents (Medical) associated with Perrigo Israel Pharmaceuticals Ltd.
100 Deals associated with Perrigo Israel Pharmaceuticals Ltd.
100 Translational Medicine associated with Perrigo Israel Pharmaceuticals Ltd.